LEVI (LEVI) director Jeffrey Jones II receives 62-share dividend equivalent grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Jones Jeffrey J II reported acquisition or exercise transactions in this Form 4 filing.

LEVI STRAUSS & CO director Jeffrey J. Jones II received a grant of 62 shares of Class A Common Stock on May 6, 2026, recorded at a price of $0.00 per share. Following this award, he directly holds 10,523 shares. The grant represents dividend equivalent rights that vest and are delivered in line with the underlying awards, generally vesting 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Jones Jeffrey J II

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	62	$0.00	--

Holdings After Transaction: Class A Common Stock — 10,523 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares granted: 62 shares Grant price: $0.00 per share Shares held after: 10,523 shares

3 metrics

Shares granted 62 shares Class A Common Stock grant on May 6, 2026

Grant price $0.00 per share Dividend equivalent rights award

Shares held after 10,523 shares Director’s direct holdings following the grant

Key Terms

dividend equivalent rights, contingent right, deferred delivery feature, Annual Stockholder Meeting

4 terms

dividend equivalent rights financial

"Represents dividend equivalent rights (DERs), each of which represents a contingent right"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

contingent right financial

"each of which represents a contingent right to receive one share"

deferred delivery feature financial

"Certain underlying awards are fully vested and are subject to a deferred delivery feature"

Annual Stockholder Meeting financial

"vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

Form 4 Insider Transactions: What Each Field Means →

05/08/2026 - 06:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones Jeffrey J II

(Last)

(First)

(Middle)

C/O LEVI STRAUSS & CO.

1155 BATTERY ST

(Street)

SAN FRANCISCO

CALIFORNIA

94111

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEVI STRAUSS & CO [ LEVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	05/06/2026		A		62⁽¹⁾	A	$0.00	10,523	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs

	/s/ Priscilla Duncan-Tannous, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did LEVI director Jeffrey J. Jones II report in this Form 4?

Director Jeffrey J. Jones II reported receiving a grant of 62 shares of LEVI Class A Common Stock at $0.00 per share. After this dividend equivalent rights award, his direct holdings increased to 10,523 shares of Class A Common Stock.

How many LEVI shares does Jeffrey J. Jones II hold after this transaction?

After the reported grant, Jeffrey J. Jones II directly holds 10,523 shares of LEVI Class A Common Stock. This total includes the 62 shares associated with the dividend equivalent rights award disclosed in the Form 4 filing.

What type of award did Jeffrey J. Jones II receive from LEVI?

He received dividend equivalent rights (DERs), each representing a contingent right to one share of LEVI Class A Common Stock upon settlement. These DERs are tied to underlying awards and follow the same vesting and delivery schedule as those awards.

How do the dividend equivalent rights for LEVI shares vest for Jeffrey J. Jones II?

The dividend equivalent rights vest and are delivered consistent with the related underlying awards. Unvested awards and their DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date.

Are any of Jeffrey J. Jones II’s LEVI awards subject to deferred delivery?

Certain underlying awards for Jeffrey J. Jones II are fully vested but subject to a deferred delivery feature. The same deferred delivery terms apply to the related dividend equivalent rights tied to those fully vested underlying awards.